Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) — The “Europe Specialty Generics Market by Route of Administration, Indication, Distributional Channel, and Region 2025-2033” report has been added to ResearchAndMarkets.com’s offering.
The Europe specialty generics market size reached USD 21.5 Billion in 2024. Looking forward, the market is forecast to reach USD 42 Billion by 2033, exhibiting a growth rate (CAGR) of 7.34% during 2025-2033. The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market.
Europe specialty generics market is primarily boosted by the growing geriatric population, increasing prevalence of chronic diseases, and the rising demand for affordable medicines. Additionally, the implementation of favorable regulatory guidelines by the European Medicines Agency (EMA) and the increasing adoption of biosimilars are boosting the market growth. Apart from this, several manufacturers are developing cost-effective biosimilars that offer similar efficacy and safety as branded drugs, which is providing an impetus to the market growth.
Furthermore, burgeoning investments by leading pharmaceutical companies in research and development (R&D) activities to develop innovative drugs and the rising awareness about the benefits of specialty generic drugs are providing a considerable thrust to the market growth. Moreover, the integration of robotics and artificial intelligence (AI) in the manufacturing process to enable automation, reduce manual labor, maintain product quality, and enhance overall efficiency is positively influencing the market growth.
Besides this, the increasing focus on expanding the product portfolio by key players, the growing demand for personalized medicine, the surging adoption of e-prescriptions, the increasing consumer awareness and acceptance of specialty generics, rising healthcare expenditure, extensive research and development (R&D) activities, and the development of novel drug delivery technologies are accelerating the market growth.
Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2025-2033. The report has categorized the market based on route of administration, indication and distribution channel.
Route of Administration Insights
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the route of administration. This includes injectables, oral, and others. According to the report, the injectables segment dominates the market.
Indication Insights
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the indication. This includes oncology, autoimmune diseases, infectious diseases, and others. According to the report, the oncology segment dominates the market.
Distributional Channel Insights
The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the distributional channel. This includes retail pharmacies, specialty pharmacies, and hospital pharmacies. According to the report, the retail pharmacies segment holds the largest market share.
Regional Insights
The report has also provided a comprehensive analysis of all the major regional markets, which include. Italy, Germany, France, the United Kingdom, Spain, and the Rest of Europe. As per the report, Italy dominates the market. Some of the factors accelerating the Italy specialty generics market include the surging awareness regarding the advantages of specialty generics, inflating consumer per capita income, and the growing prevalence of chronic diseases.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the Europe specialty generics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. The leading players in the European specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the Europe specialty generics market in 2024?
2. What is the expected growth rate of the Europe specialty generics market during 2025-2033?
3. What are the key factors driving the Europe specialty generics market?
4. What has been the impact of COVID-19 on the Europe specialty generics market?
5. What is the breakup of the Europe specialty generics market based on the route of administration?
6. What is the breakup of the Europe specialty generics market based on the indication?
7. What is the breakup of the Europe specialty generics market based on the distribution channel?
8. What are the key regions in the Europe specialty generics market?
Key Attributes
Report AttributeDetailsNo. of Pages140Forecast Period2024-2033Estimated Market Value (USD) in 2024$21.5 BillionForecasted Market Value (USD) by 2033$42 BillionCompound Annual Growth Rate7.7%Regions CoveredEurope
For more information about this report visit https://www.researchandmarkets.com/r/6v4vsw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Specialty Generics Market
